Pseudomonas aeruginosa Phenotypes Associated With Eradication Failure in Children With Cystic Fibrosis

被引:62
|
作者
Mayer-Hamblett, Nicole [1 ,2 ,6 ]
Ramsey, Bonnie W. [1 ,6 ]
Kulasekara, Hemantha D. [3 ]
Wolter, Daniel J. [1 ]
Houston, Laura S. [1 ]
Pope, Christopher E. [1 ]
Kulasekara, Bridget R. [3 ]
Armbruster, Catherine R. [3 ]
Burns, Jane L. [1 ,6 ]
Retsch-Bogart, George [7 ]
Rosenfeld, Margaret [1 ,6 ]
Gibson, Ronald L. [1 ,6 ]
Miller, Samuel I. [3 ,4 ,5 ]
Khan, Umer [6 ]
Hoffman, Lucas R. [1 ,3 ,6 ]
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98105 USA
[3] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
[4] Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA
[5] Univ Washington, Dept Med, Seattle, WA 98105 USA
[6] Seattle Childrens Hosp, Washington, DC USA
[7] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA
基金
美国国家卫生研究院;
关键词
cystic fibrosis; Pseudomonas aeruginosa; phenotypic characterization; eradication; antibiotic treatment; YOUNG-CHILDREN; COLONY MORPHOLOGY; LUNG-FUNCTION; LASR MUTANTS; INFECTION; ADAPTATION; TOBRAMYCIN; DISEASE; AIRWAYS; DIVERSIFICATION;
D O I
10.1093/cid/ciu385
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Pseudomonas aeruginosa is a key respiratory pathogen in people with cystic fibrosis (CF). Due to its association with lung disease progression, initial detection of P. aeruginosa in CF respiratory cultures usually results in antibiotic treatment with the goal of eradication. Pseudomonas aeruginosa exhibits many different phenotypes in vitro that could serve as useful prognostic markers, but the relative relationships between these phenotypes and failure to eradicate P. aeruginosa have not been well characterized. Methods. We measured 22 easily assayed in vitro phenotypes among the baseline P. aeruginosa isolates collected from 194 participants in the 18-month EPIC clinical trial, which assessed outcomes after antibiotic eradication therapy for newly identified P. aeruginosa. We then evaluated the associations between these baseline isolate phenotypes and subsequent outcomes during the trial, including failure to eradicate after antipseudomonal therapy, emergence of mucoidy, and occurrence of an exacerbation. Results. Baseline P. aeruginosa isolates frequently exhibited phenotypes thought to represent chronic adaptation, including mucoidy. Wrinkly colony surface and irregular colony edges were both associated with increased risk of eradication failure (hazard ratios [95% confidence intervals], 1.99 [1.03-3.83] and 2.14 [1.32-3.47], respectively). Phenotypes reflecting defective quorum sensing were significantly associated with subsequent mucoidy, but no phenotype was significantly associated with subsequent exacerbations during the trial. Conclusions. Pseudomonas aeruginosa phenotypes commonly considered to reflect chronic adaptation were observed frequently among isolates at early detection. We found that 2 easily assayed colony phenotypes were associated with failure to eradicate after antipseudomonal therapy, both of which have been previously associated with altered biofilm formation and defective quorum sensing.
引用
收藏
页码:624 / 631
页数:8
相关论文
共 50 条
  • [21] Successful Eradication of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis
    Singh, J. A.
    Lynch, S.
    Iredell, J.
    Selvadurai, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [22] Eradication treatment of Pseudomonas Aeruginosa in pediatric patients with Cystic Fibrosis
    Gulieva, A.
    Yegit, C. Yilmaz
    Yanaz, M.
    Kalyoncu, M.
    Selcuk, M.
    Tastan, G.
    Suzer, B.
    Ergenekon, P.
    Eralp, E. Erdem
    Gokdemir, Y.
    Karakoc, F.
    Karadag, B.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [23] PSEUDOMONAS AERUGINOSA ERADICATION IN CYSTIC FIBROSIS PATIENTS: A RETROSPECTIVE REVIEW
    Gerwin, A. M.
    Britton, L. J.
    Benner, K.
    Tofil, N.
    Guiterrez, H.
    Troxler, R. B.
    Hoover, W. C.
    PEDIATRIC PULMONOLOGY, 2009, : 339 - 339
  • [24] Eradication of initial pseudomonas aeruginosa colonization in patients with cystic fibrosis
    Griese, M
    Müller, I
    Reinhardt, D
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2002, 7 (02) : 79 - 80
  • [25] Pseudomonas aeruginosa and Children With Cystic Fibrosis COMMENT
    Sala, Marc A.
    Jain, Mane
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2529 - E2530
  • [26] Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis
    Psoter, K. J.
    De Roos, A. J.
    Wakefield, J.
    Rosenfeld, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (11) : 1063 - 1064
  • [27] Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis
    Farrell, PM
    Shen, GH
    Splaingard, M
    Colby, CE
    Laxova, A
    Kosorok, MR
    Rock, MJ
    Mischler, EH
    PEDIATRICS, 1997, 100 (05) : E2
  • [28] The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
    Morris, Amanda J.
    Jackson, Lindsay
    Yau, Yvonne C. W.
    Reichhardt, Courtney
    Beaudoin, Trevor
    Uwumarenogie, Stephanie
    Guttman, Kevin M.
    Howell, P. Lynne
    Parsek, Matthew R.
    Hoffman, Lucas R.
    Dao Nguyen
    DiGiandomenico, Antonio
    Guttman, David S.
    Wozniak, Daniel J.
    Waters, Valerie J.
    NPJ BIOFILMS AND MICROBIOMES, 2021, 7 (01)
  • [29] The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
    Amanda J. Morris
    Lindsay Jackson
    Yvonne CW Yau
    Courtney Reichhardt
    Trevor Beaudoin
    Stephanie Uwumarenogie
    Kevin M. Guttman
    P. Lynne Howell
    Matthew R. Parsek
    Lucas R. Hoffman
    Dao Nguyen
    Antonio DiGiandomenico
    David S. Guttman
    Daniel J. Wozniak
    Valerie J. Waters
    npj Biofilms and Microbiomes, 7
  • [30] THE EFFECT OF PSEUDOMONAS AERUGINOSA PHENOTYPE AND THE PULMONARY MICROBIOME ON THE SUCCESS OF ERADICATION THERAPY IN CHILDREN WITH CYSTIC FIBROSIS
    Waters, V. J.
    Vidya, P.
    Coburn, B.
    Smith, L.
    Yau, Y.
    Hwang, D.
    Guttman, D.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 319 - 319